{
  "fullName": "Denis Logunov",
  "slug": "denis-logunov",
  "title": "MD",
  "specialty": "Virology",
  "geography": {
    "country": "Global",
    "city": "Unknown",
    "region": "Unknown"
  },
  "status": "LIVING",
  "tier": "UNRANKED",
  "rankingScore": 23.8,
  "hIndex": 30,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Sputnik V or Gam-COVID-Vac is an adenovirus viral vector vaccine for COVID-19 developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia. It is the world's first registered combination vector vaccine for the prevention of COVID-19, having been registered on 11 August 2020 by the Russian Ministry of Health.",
  "aiSummary": "Denis Logunov is a virology specialist with an H-index of 30 at Gamaleya Research Institute (Member). Has been published in The Lancet, Proceedings of the National Academy of Sciences, The Lancet Regional Health - Europe. Based in Unknown, Unknown, Global.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "Gamaleya Research Institute"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Gamaleya Research Institute",
      "role": "Member",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Virology"
  ],
  "knowsAbout": [
    "Government Science Award"
  ],
  "citations": [
    {
      "title": "Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia",
      "journal": "The Lancet",
      "year": 2021,
      "citationCount": 1810,
      "doi": "10.1016/s0140-6736(21)00234-8",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(21)00234-8",
      "verified": true
    },
    {
      "title": "Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia",
      "journal": "The Lancet",
      "year": 2020,
      "citationCount": 1112,
      "doi": "10.1016/s0140-6736(20)31866-3",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(20)31866-3",
      "verified": true
    },
    {
      "title": "Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia",
      "journal": "Human Vaccines & Immunotherapeutics",
      "year": 2017,
      "citationCount": 132,
      "doi": "10.1080/21645515.2016.1238535",
      "sourceUrl": "https://doi.org/10.1080/21645515.2016.1238535",
      "verified": true
    },
    {
      "title": "Central role of liver in anticancer and radioprotective activities of Toll-like receptor 5 agonist",
      "journal": "Proceedings of the National Academy of Sciences",
      "year": 2013,
      "citationCount": 120,
      "doi": "10.1073/pnas.1222805110",
      "sourceUrl": "https://doi.org/10.1073/pnas.1222805110",
      "verified": true
    },
    {
      "title": "Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants",
      "journal": "Vaccines",
      "year": 2021,
      "citationCount": 118,
      "doi": "10.3390/vaccines9070779",
      "sourceUrl": "https://doi.org/10.3390/vaccines9070779",
      "verified": true
    },
    {
      "title": "Association of <i>Mycoplasma hominis</i> infection with prostate cancer",
      "journal": "Oncotarget",
      "year": 2011,
      "citationCount": 114,
      "doi": "10.18632/oncotarget.256",
      "sourceUrl": "https://doi.org/10.18632/oncotarget.256",
      "verified": true
    },
    {
      "title": "Receptor Mincle promotes skin allergies and is capable of recognizing cholesterol sulfate",
      "journal": "Proceedings of the National Academy of Sciences",
      "year": 2017,
      "citationCount": 88,
      "doi": "10.1073/pnas.1611665114",
      "sourceUrl": "https://doi.org/10.1073/pnas.1611665114",
      "verified": true
    },
    {
      "title": "Toll-Like Receptors (TLRs): The Role in Tumor Progression",
      "journal": "Acta Naturae",
      "year": 2010,
      "citationCount": 80,
      "doi": "10.32607/20758251-2010-2-3-21-29",
      "sourceUrl": "https://doi.org/10.32607/20758251-2010-2-3-21-29",
      "verified": true
    },
    {
      "title": "Mycoplasma infection suppresses p53, activates NF-κB and cooperates with oncogenic Ras in rodent fibroblast transformation",
      "journal": "Oncogene",
      "year": 2008,
      "citationCount": 79,
      "doi": "10.1038/onc.2008.103",
      "sourceUrl": "https://doi.org/10.1038/onc.2008.103",
      "verified": true
    },
    {
      "title": "An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine “Sputnik Light” for prevention of coronavirus infection in healthy adults",
      "journal": "The Lancet Regional Health - Europe",
      "year": 2021,
      "citationCount": 71,
      "doi": "10.1016/j.lanepe.2021.100241",
      "sourceUrl": "https://doi.org/10.1016/j.lanepe.2021.100241",
      "verified": true
    },
    {
      "title": "Camelid VHHs Fused to Human Fc Fragments Provide Long Term Protection Against Botulinum Neurotoxin A in Mice",
      "journal": "Toxins",
      "year": 2019,
      "citationCount": 70,
      "doi": "10.3390/toxins11080464",
      "sourceUrl": "https://doi.org/10.3390/toxins11080464",
      "verified": true
    },
    {
      "title": "Formatted single-domain antibodies can protect mice against infection with influenza virus (H5N2)",
      "journal": "Antiviral Research",
      "year": 2012,
      "citationCount": 54,
      "doi": "10.1016/j.antiviral.2012.12.014",
      "sourceUrl": "https://doi.org/10.1016/j.antiviral.2012.12.014",
      "verified": true
    },
    {
      "title": "Interactions between Sulfated Polysaccharides from Sea Brown Algae and Toll-Like Receptors on HEK293 Eukaryotic Cells In Vitro",
      "journal": "Bulletin of Experimental Biology and Medicine",
      "year": 2012,
      "citationCount": 52,
      "doi": "10.1007/s10517-012-1922-2",
      "sourceUrl": "https://doi.org/10.1007/s10517-012-1922-2",
      "verified": true
    },
    {
      "title": "Recombinant Influenza Vaccines",
      "journal": "Acta Naturae",
      "year": 2012,
      "citationCount": 47,
      "doi": "10.32607/20758251-2012-4-4-17-27",
      "sourceUrl": "https://doi.org/10.32607/20758251-2012-4-4-17-27",
      "verified": true
    },
    {
      "title": "COVID-19: evolution of the pandemic in Russia. Report II: dynamics of the circulation of SARS-CoV-2 genetic variants",
      "journal": "Journal of microbiology epidemiology immunobiology",
      "year": 2022,
      "citationCount": 43,
      "doi": "10.36233/0372-9311-295",
      "sourceUrl": "https://doi.org/10.36233/0372-9311-295",
      "verified": true
    },
    {
      "title": "Powerful Complex Immunoadjuvant Based on Synergistic Effect of Combined TLR4 and NOD2 Activation Significantly Enhances Magnitude of Humoral and Cellular Adaptive Immune Responses",
      "journal": "PLoS ONE",
      "year": 2016,
      "citationCount": 43,
      "doi": "10.1371/journal.pone.0155650",
      "sourceUrl": "https://doi.org/10.1371/journal.pone.0155650",
      "verified": true
    },
    {
      "title": "Taxonomic-faunistic notes on the jumping spiders of the Mediterranean (Aranei: Salticidae)",
      "journal": "rej",
      "year": 2015,
      "citationCount": 43,
      "doi": "10.15298/arthsel.24.1.03",
      "sourceUrl": "https://doi.org/10.15298/arthsel.24.1.03",
      "verified": true
    },
    {
      "title": "Topical Bacterial Lipopolysaccharide Application Affects Inflammatory Response and Promotes Wound Healing",
      "journal": "Journal of Interferon & Cytokine Research",
      "year": 2013,
      "citationCount": 41,
      "doi": "10.1089/jir.2012.0108",
      "sourceUrl": "https://doi.org/10.1089/jir.2012.0108",
      "verified": true
    },
    {
      "title": "Combined Stimulation of Toll-Like Receptor 5 and NOD1 Strongly Potentiates Activity of NF-κB, Resulting in Enhanced Innate Immune Reactions and Resistance to Salmonella enterica Serovar Typhimurium Infection",
      "journal": "Infection and Immunity",
      "year": 2013,
      "citationCount": 41,
      "doi": "10.1128/iai.00525-13",
      "sourceUrl": "https://doi.org/10.1128/iai.00525-13",
      "verified": true
    },
    {
      "title": "Non-Thermal Plasma Causes P53-Dependent Apoptosis in Human Colon Carcinoma Cells",
      "journal": "Acta Naturae",
      "year": 2012,
      "citationCount": 40,
      "doi": "10.32607/20758251-2012-4-3-82-87",
      "sourceUrl": "https://doi.org/10.32607/20758251-2012-4-3-82-87",
      "verified": true
    },
    {
      "title": "Virus-Vectored Ebola Vaccines",
      "journal": "Acta Naturae",
      "year": 2017,
      "citationCount": 38,
      "doi": "10.32607/20758251-2017-9-3-4-11",
      "sourceUrl": "https://doi.org/10.32607/20758251-2017-9-3-4-11",
      "verified": true
    },
    {
      "title": "Targeting TLR-4 with a novel pharmaceutical grade plant derived agonist, Immunomax®, as a therapeutic strategy for metastatic breast cancer",
      "journal": "Journal of Translational Medicine",
      "year": 2014,
      "citationCount": 36,
      "doi": "10.1186/s12967-014-0322-y",
      "sourceUrl": "https://doi.org/10.1186/s12967-014-0322-y",
      "verified": true
    },
    {
      "title": "Development of adenoviral vector-based mucosal vaccine against influenza",
      "journal": "Journal of Molecular Medicine",
      "year": 2010,
      "citationCount": 36,
      "doi": "10.1007/s00109-010-0696-0",
      "sourceUrl": "https://doi.org/10.1007/s00109-010-0696-0",
      "verified": true
    },
    {
      "title": "Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern",
      "journal": "Frontiers in Immunology",
      "year": 2022,
      "citationCount": 35,
      "doi": "10.3389/fimmu.2022.822159",
      "sourceUrl": "https://doi.org/10.3389/fimmu.2022.822159",
      "verified": true
    },
    {
      "title": "Retention of Neutralizing Response against SARS-CoV-2 Omicron Variant in Sputnik V-Vaccinated Individuals",
      "journal": "Vaccines",
      "year": 2022,
      "citationCount": 34,
      "doi": "10.3390/vaccines10050817",
      "sourceUrl": "https://doi.org/10.3390/vaccines10050817",
      "verified": true
    },
    {
      "title": "Passive immunization with a recombinant adenovirus expressing an HA (H5)-specific single-domain antibody protects mice from lethal influenza infection",
      "journal": "Antiviral Research",
      "year": 2012,
      "citationCount": 34,
      "doi": "10.1016/j.antiviral.2012.12.021",
      "sourceUrl": "https://doi.org/10.1016/j.antiviral.2012.12.021",
      "verified": true
    },
    {
      "title": "Mycoplasma infection suppresses p53, activates NF-kappaB and cooperates with oncogenic Ras in rodent fibroblast transformation",
      "journal": "Unknown Journal",
      "year": 2008,
      "citationCount": 33,
      "doi": null,
      "sourceUrl": "https://openalex.org/W2968126610",
      "verified": true
    },
    {
      "title": "A Deep Look Into COVID-19 Severity Through Dynamic Changes in Blood Cytokine Levels",
      "journal": "Frontiers in Immunology",
      "year": 2021,
      "citationCount": 33,
      "doi": "10.3389/fimmu.2021.771609",
      "sourceUrl": "https://doi.org/10.3389/fimmu.2021.771609",
      "verified": true
    },
    {
      "title": "Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Specific T Cells and Antibodies in Coronavirus Disease 2019 (COVID-19) Protection: A Prospective Study",
      "journal": "Clinical Infectious Diseases",
      "year": 2022,
      "citationCount": 32,
      "doi": "10.1093/cid/ciac278",
      "sourceUrl": "https://doi.org/10.1093/cid/ciac278",
      "verified": true
    },
    {
      "title": "Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts",
      "journal": "PLoS ONE",
      "year": 2018,
      "citationCount": 32,
      "doi": "10.1371/journal.pone.0191574",
      "sourceUrl": "https://doi.org/10.1371/journal.pone.0191574",
      "verified": true
    },
    {
      "title": "Sputnik V Effectiveness against Hospitalization with COVID-19 during Omicron Dominance",
      "journal": "Vaccines",
      "year": 2022,
      "citationCount": 29,
      "doi": "10.3390/vaccines10060938",
      "sourceUrl": "https://doi.org/10.3390/vaccines10060938",
      "verified": true
    },
    {
      "title": "In Vitro Efficacy of Antivirals and Monoclonal Antibodies against SARS-CoV-2 Omicron Lineages XBB.1.9.1, XBB.1.9.3, XBB.1.5, XBB.1.16, XBB.2.4, BQ.1.1.45, CH.1.1, and CL.1",
      "journal": "Vaccines",
      "year": 2023,
      "citationCount": 28,
      "doi": "10.3390/vaccines11101533",
      "sourceUrl": "https://doi.org/10.3390/vaccines11101533",
      "verified": true
    },
    {
      "title": "The Effect of a BSA Conjugate of a Synthetic Hexasaccharide Related to the Fragment of Capsular Polysaccharide of Streptococcus pneumoniae Type 14 on the Activation of Innate and Adaptive Immune Responses",
      "journal": "Frontiers in Immunology",
      "year": 2016,
      "citationCount": 28,
      "doi": "10.3389/fimmu.2016.00248",
      "sourceUrl": "https://doi.org/10.3389/fimmu.2016.00248",
      "verified": true
    },
    {
      "title": "Single-domain antibody delivery using an mRNA platform protects against lethal doses of botulinum neurotoxin A",
      "journal": "Frontiers in Immunology",
      "year": 2023,
      "citationCount": 28,
      "doi": "10.3389/fimmu.2023.1098302",
      "sourceUrl": "https://doi.org/10.3389/fimmu.2023.1098302",
      "verified": true
    },
    {
      "title": "Safety and efficacy of the Russian COVID-19 vaccine: more information needed – Authors’ reply",
      "journal": "The Lancet",
      "year": 2020,
      "citationCount": 27,
      "doi": "10.1016/s0140-6736(20)31970-x",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(20)31970-x",
      "verified": true
    },
    {
      "title": "Restoration of p53 tumor-suppressor activity in human tumor cells in vitro and in their xenografts in vivo by recombinant avian adenovirus CELO-p53",
      "journal": "Gene Therapy",
      "year": 2003,
      "citationCount": 26,
      "doi": "10.1038/sj.gt.3302146",
      "sourceUrl": "https://doi.org/10.1038/sj.gt.3302146",
      "verified": true
    },
    {
      "title": "Spinal Cord Molecular and Cellular Changes Induced by Adenoviral Vector- and Cell-Mediated Triple Gene Therapy after Severe Contusion",
      "journal": "Frontiers in Pharmacology",
      "year": 2017,
      "citationCount": 26,
      "doi": "10.3389/fphar.2017.00813",
      "sourceUrl": "https://doi.org/10.3389/fphar.2017.00813",
      "verified": true
    },
    {
      "title": "New Therapy for Spinal Cord Injury: Autologous Genetically-Enriched Leucoconcentrate Integrated with Epidural Electrical Stimulation",
      "journal": "Cells",
      "year": 2022,
      "citationCount": 25,
      "doi": "10.3390/cells11010144",
      "sourceUrl": "https://doi.org/10.3390/cells11010144",
      "verified": true
    },
    {
      "title": "Codon optimization and improved delivery/immunization regimen enhance the immune response against wild-type and drug-resistant HIV-1 reverse transcriptase, preserving its Th2-polarity",
      "journal": "Scientific Reports",
      "year": 2018,
      "citationCount": 24,
      "doi": "10.1038/s41598-018-26281-z",
      "sourceUrl": "https://doi.org/10.1038/s41598-018-26281-z",
      "verified": true
    },
    {
      "title": "Sputnik Light booster after Sputnik V vaccination induces robust neutralizing antibody response to B.1.1.529 (Omicron) SARS-CoV-2 variant",
      "journal": "Unknown Journal",
      "year": 2021,
      "citationCount": 22,
      "doi": "10.1101/2021.12.17.21267976",
      "sourceUrl": "https://doi.org/10.1101/2021.12.17.21267976",
      "verified": true
    },
    {
      "title": "Cytogenetic studies on seventeen spider species from Israel",
      "journal": "Unknown Journal",
      "year": 1997,
      "citationCount": 21,
      "doi": null,
      "sourceUrl": "https://openalex.org/W2184437931",
      "verified": true
    },
    {
      "title": "Adjuvantation of an Influenza Hemagglutinin Antigen with TLR4 and NOD2 Agonists Encapsulated in Poly(D,L-Lactide-Co-Glycolide) Nanoparticles Enhances Immunogenicity and Protection against Lethal Influenza Virus Infection in Mice",
      "journal": "Vaccines",
      "year": 2020,
      "citationCount": 21,
      "doi": "10.3390/vaccines8030519",
      "sourceUrl": "https://doi.org/10.3390/vaccines8030519",
      "verified": true
    },
    {
      "title": "Toll-like receptors and their adapter molecules",
      "journal": "Biochemistry (Moscow)",
      "year": 2010,
      "citationCount": 20,
      "doi": "10.1134/s0006297910090038",
      "sourceUrl": "https://doi.org/10.1134/s0006297910090038",
      "verified": true
    },
    {
      "title": "Retention of Neutralizing response against SARS-CoV-2 Omicron variant in Sputnik V vaccinated individuals",
      "journal": "Unknown Journal",
      "year": 2022,
      "citationCount": 20,
      "doi": "10.1101/2022.01.15.22269335",
      "sourceUrl": "https://doi.org/10.1101/2022.01.15.22269335",
      "verified": true
    },
    {
      "title": "Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial – Authors' reply",
      "journal": "The Lancet",
      "year": 2021,
      "citationCount": 20,
      "doi": "10.1016/s0140-6736(21)00894-1",
      "sourceUrl": "https://doi.org/10.1016/s0140-6736(21)00894-1",
      "verified": true
    },
    {
      "title": "Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates",
      "journal": "Emerging Microbes & Infections",
      "year": 2022,
      "citationCount": 20,
      "doi": "10.1080/22221751.2022.2119169",
      "sourceUrl": "https://doi.org/10.1080/22221751.2022.2119169",
      "verified": true
    },
    {
      "title": "Dynamics of SARS-CoV-2 Major Genetic Lineages in Moscow in the Context of Vaccine Prophylaxis",
      "journal": "International Journal of Molecular Sciences",
      "year": 2022,
      "citationCount": 19,
      "doi": "10.3390/ijms232314670",
      "sourceUrl": "https://doi.org/10.3390/ijms232314670",
      "verified": true
    },
    {
      "title": "Nanobodies Are Potential Therapeutic Agents for the Ebola Virus Infection",
      "journal": "Acta Naturae",
      "year": 2021,
      "citationCount": 19,
      "doi": "10.32607/actanaturae.11487",
      "sourceUrl": "https://doi.org/10.32607/actanaturae.11487",
      "verified": true
    },
    {
      "title": "Genetic Passive Immunization with Adenoviral Vector Expressing Chimeric Nanobody-Fc Molecules as Therapy for Genital Infection Caused by Mycoplasma hominis",
      "journal": "PLoS ONE",
      "year": 2016,
      "citationCount": 19,
      "doi": "10.1371/journal.pone.0150958",
      "sourceUrl": "https://doi.org/10.1371/journal.pone.0150958",
      "verified": true
    },
    {
      "title": "The differences in immunoadjuvant mechanisms of TLR3 and TLR4 agonists on the level of antigen-presenting cells during immunization with recombinant adenovirus vector",
      "journal": "BMC Immunology",
      "year": 2018,
      "citationCount": 19,
      "doi": "10.1186/s12865-018-0264-x",
      "sourceUrl": "https://doi.org/10.1186/s12865-018-0264-x",
      "verified": true
    }
  ],
  "awards": [],
  "timeline": [],
  "openalexId": "https://openalex.org/A5005313486",
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/4/43/%D0%92%D0%B0%D0%BA%D1%86%D0%B8%D0%BD%D0%B0_%D0%A1%D0%BF%D1%83%D1%82%D0%BD%D0%B8%D0%BA_V_%28cropped%29.jpg"
}